Omalizumab for severe allergic keratoconjunctivitis: A case series
The Journal of Allergy and Clinical Immunology: In Practice · 2023-11 · 11 (11) · 3528-3530
DOI: 10.1016/j.jaip.2023.07.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023-11. Verfasst von Marie Mercier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergology, Armand Trousseau University Hospital, Groupe Hospitalier Universitaire, AP-HP Sorbonne-University, Paris, France. Hauptthemen laut MEDLINE: Anti-Allergic Agents, Hypersensitivity, Keratoconjunctivitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Allergology, Armand Trousseau University Hospital, Groupe Hospitalier Universitaire, AP-HP Sorbonne-University, Paris, France.
- Department of Ophthalmology, Bichat Hospital, Groupe Hospitalier Universitaire, AP-HP Nord-University de Paris, Paris, France; Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France.
- Department of Ophthalmology, Bichat Hospital, Groupe Hospitalier Universitaire, AP-HP Nord-University de Paris, Paris, France; Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France; Department…
- Department of Respiratory Diseases, Bichat Hospital, Groupe Hospitalier Universitaire, AP-HP Nord-University de Paris, Paris, France.
- Department of Pediatric Allergology, Armand Trousseau University Hospital, Groupe Hospitalier Universitaire, AP-HP Sorbonne-University, Paris, France. Electronic address: stephanie.wanin@aphp.fr.
Zitieren
APA
Mercier, M., Doan, S., Elaouane, I., Chelly, Z., Bourgoin-Heck, M., Lambert, N., Cottel, N., Taillé, C., & Wanin, S. (2023). Omalizumab for severe allergic keratoconjunctivitis: A case series. The Journal of Allergy and Clinical Immunology: In Practice, 11(11), 3528-3530. https://doi.org/10.1016/j.jaip.2023.07.016
Vancouver
Mercier M, Doan S, Elaouane I, Chelly Z, Bourgoin-Heck M, Lambert N, et al. Omalizumab for severe allergic keratoconjunctivitis: A case series. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(11):3528-3530. doi:10.1016/j.jaip.2023.07.016
BibTeX
@article{Mercier2023,
author = {Mercier, Marie and Doan, Serge and Elaouane, Imane and Chelly, Zied and Bourgoin-Heck, Mélisande and Lambert, Nathalie and Cottel, Nathalie and Taillé, Camille and Wanin, Stéphanie},
title = {Omalizumab for severe allergic keratoconjunctivitis: A case series},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2023},
volume = {11},
number = {11},
pages = {3528--3530},
doi = {10.1016/j.jaip.2023.07.016}
}
EUVIMED